<ul data-eligibleForWebStory="true"><li>Arine raises $30M in Series C funding led by Town Hall Ventures and Kaiser Permanente Ventures, bringing total funding to $66M.</li><li>The funding will help Arine redefine medication management in healthcare to address financial and regulatory challenges.</li><li>Medications are crucial for improving outcomes and controlling costs in healthcare, and Arine's AI platform aims to deliver personalized and cost-effective medication therapy.</li><li>Arine's AI platform identifies individuals for intervention, recommends effective therapies, and measures impact, resulting in over 10% cost savings and 40% reduction in hospitalizations for clients.</li><li>The company has achieved over 100% growth in the last year with an 80% average contract expansion with existing clients.</li><li>Arine plans to expand its specialty pharmacy management capabilities, automate tasks through AI innovation, and personalize medication therapy further with comprehensive data integration.</li></ul>

Arine Raises $30M to Redefine Medication Management with AI

Discover more